Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma

Bhavsar P., Khorasani N., Hew M., Johnson M., Chung K. F.

Source: Eur Respir J 2010; 35: 750-756
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bhavsar P., Khorasani N., Hew M., Johnson M., Chung K. F.. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma. Eur Respir J 2010; 35: 750-756

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Corticosteroids reduce pro-inflammatory cytokine expression in airway smooth muscle cells via upregulation of MAPK phosphatase-1 and inhibition of p38 MAPK signalling
Source: Eur Respir J 2005; 26: Suppl. 49, 713s
Year: 2005

Inhibition of P38 kinase does not reduce production of TNF-alpha from airway cells in COPD
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Effect of PDE4 inhibitors on MAPK activation and IL-8 production on A549 cells following the induction of oxidative stress
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005

Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Induced sputum differential gene expression implicates increased p38 signalling activity in severe asthma
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


Ceramide-1-phosphate decreases allergic airway inflammation, remodeling and hyperresponsiveness by inhibition of phosphorilation of NF-kappa B, Akt, MAPK p-38 in dendritic cells
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure
Source: Eur Respir J 2005; 25: 797-803
Year: 2005



N-Acetylcysteine inhibits eotaxin and MCP-1 release in human airway smooth muscle cells in vitro through the inhibition of ROS production, resulting in a decrease of p38 MAP kinase activation
Source: Eur Respir J 2002; 20: Suppl. 38, 170s
Year: 2002

Role of dexamethasone and MAPkinases ERK and p38MAPK on T-bet expression and IFNγ release in peripheral blood lymphocytes from atopic asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006

Exposure to LPS induces the upregulation of p38 MAPK in human bronchial epithelium in vivo
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003

The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD
Source: Annual Congress 2008 - Novel treatments for respiratory disease
Year: 2008


Corticosteroid insensitivity and enhanced mitogen-activated protein kinase activity in airway smooth muscle cells of severe asthma
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011


Transforming growth factor-β inhibition of lung fibroblast proliferation is mediated through prostaglandin E2, via activation of p38 mitogen-activated protein kinase
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


The p38 MAP kinase inhibitor dilmapimod ameliorates airway inflammation induced by ozone challenge in healthy volunteers
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Effects of TGF-beta and budesonide on MAPK phosphorylation, IL-6/IL-11 secretion, and cell proliferation in human lung fibroblasts
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006

Effect of non-steroidal anti-inflammatory drugs on neutrophil recruitment, p38 map kinase phosphorylation and NF-κB activation in lung from mice exposed to cigarette smoke
Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Year: 2007